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Abstract It is often believed that increases in intracellular Ca2+
([Ca2+]i) resulting from stimulation of G-protein coupled
receptors in vascular smooth muscle cells (VSMC) require
activation of the L1 isoform of phospholipase C (PLC). However,
recent studies showed that rat aortic VSMC do not express PLC
L-1 and that stimulation with angiotensin-II induces tyrosine
kinase dependent increases in [Ca2+]i and tyrosine phosphoryla-
tion of PLC Q-1. Whether this pathway is activated by other
vasoactive agents that stimulate G-protein coupled receptors is
unknown. Here, we show that A10 VSMC express PLC L-2,
PLC L-3, PLC N-1, and PLC Q-1. The cells also expressed
GKq=11. However, neither PLC L-1 nor PLC L-4 was detected.
Stimulation with angiotensin-II, vasopressin, serotonin, or
endothelin induced tyrosine kinase dependent increases in
[Ca2+]i. However, tyrosine phosphorylation of PLC Q-1 did not
occur. In contrast, stimulation with platelet derived growth factor
increased [Ca2+]i and tyrosine phosphorylation of PLC Q-1. The
results show that tyrosine phosphorylation of PLC Q-1 is not
required for tyrosine kinase dependent increases in [Ca2+]i
resulting from stimulation of diverse G-protein coupled receptors
in VSMC.
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1. Introduction
Phospholipase C (PLC) has been assigned a key role in
mediating increases in intracellular Ca2 ([Ca2]i) that occur
in vascular smooth muscle cells (VSMC) when G-protein
coupled receptors are stimulated with vasoactive agents [1^
4]. Activated PLC generates two second messengers: one, in-
ositol 1,4,5-trisphosphate, induces release of Ca2 from the
sarcoplasmic reticulum, while the other, diacylglycerol, acti-
vates protein kinase C.
However, because multiple isoforms of PLC exist, uncer-
tainties arise regarding the identity of the relevant isoform
in VSMC and how it is activated. At least 10 isoforms of
PLC belonging to three families designated L, Q, and N have
been identi¢ed in mammalian cells [4^6]. Activation of PLC L
isoforms is linked to stimulation of G-protein coupled recep-
tors, whereas activation of PLC Q isoforms is largely mediated
by its direct tyrosine phosphorylation. Mechanisms for acti-
vation of N isoforms are unknown. The currently prevalent
view for VSMC is that stimulation induces activation of a
trimeric G-protein containing an K subunit of the q type
which, in turn, activates the L-1 isoform of PLC. Recently,
this view has been questioned because PLC L-1 was not de-
tected in several VSMC preparations [7^9]. Moreover, grow-
ing evidence suggests that protein tyrosine kinase activity may
modulate increases in [Ca2]i evoked by stimulation of diverse
G-protein coupled receptors [7,10^13]. In this context, stimu-
lation of rat VSMC with angiotensin II induced tyrosine
phosphorylation of PLC Q-1, generation of inositol 1,4,5-tris-
phosphate, and increases in [Ca2]i [7]. However, whether or
not angiotensin-II induces tyrosine phosphorylation of PLC Q-
1 in di¡erent VSMC that lack PLC L-1 is unknown. Similarly,
whether or not tyrosine phosphorylation of PLC Q-1 is a
common mechanism for linking stimulation of di¡erent G-
protein coupled receptors to [Ca2]i also is unknown.
Our earlier studies showed that tyrosine kinase dependent
increases in [Ca2]i were evoked in A10 and other VSMC
stimulated with diverse vasoactive agents [10^15]. However,
PLC expression was not determined. In this study, we show
that although A10 cells express several isoforms of PLC, PLC
L-1 was not detected. Expectedly [7^10], angiotensin-II evoked
increases in [Ca2]i were tyrosine kinase dependent. Surpris-
ingly, no tyrosine phosphorylation of PLC Q-1 occurred.
Moreover, no tyrosine phosphorylation of PLC Q-1 occurred
when increases in [Ca2]i were induced with three other vaso-
active agents that stimulate di¡erent G-protein coupled recep-
tors. These new data show that tyrosine phosphorylation of
PLC Q-1 is not obligatory for tyrosine kinase dependent in-
creases in [Ca2]i that occur in response to stimulation of G-
protein coupled receptors in A10 VSMC.
2. Materials and methods
2.1. Cell culture and fura-2 £uorescence analysis
Methods for culturing A10 aortic smooth muscle cells (ATCC) and
for radiometric £uorescence analysis of changes in [Ca2]i in fura-2
loaded cells were described previously [12,14,15]. The cells were ex-
cited at 340 and 380 nm and emission was monitored at 510 nm.
Changes in the 340/380 £uorescence ratio were used as a measure of
changes in [Ca2]i.
The concentrations of agonists tested were: 50 nM angiotensin-II
(Peninsula Labs), 20 nM [arg8]-vasopressin (Sigma), 1 WM serotonin
(Calbiochem), and 400 nM endothelin (Peninsula Labs.). Responses
evoked by 1 nM platelet derived growth factor (PDGF; AB isomer,
UBI) were also examined as a representative agent that acts through a
tyrosine kinase receptor rather than a G-protein coupled receptor [16].
To assess the requirement for tyrosine kinase activity, experiments
were performed before and after preincubation with 105 WM genistein
(Calbiochem). Earlier studies showed that this concentration of gen-
istein virtually abolished increases in tyrosine phosphorylation and
[Ca2]i that were evoked by diverse vasoactive agents in di¡erent
VSMC without altering the activity of several serine/threonine kin-
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ases, including myosin light chain kinase and cAMP dependent pro-
tein kinase [10^15].
2.2. Immunoblotting: expression of PLC isoforms
Extracts were prepared from cells grown to 80^90% con£uency in
75 cm2 T-£asks, serum deprived for 48 h, and lysed in bu¡er contain-
ing 1% Triton X, 25 mM Tris-HCl (pH 7.5), 10% glycerol, 1 mM Na
vanadate, 10 mM Na pyrophosphate, 50 mM NaF, 1 mM phenyl-
methylsulfonyl £uoride, and 10 Wg/ml leupeptin. The lysate was cen-
trifuged, and the supernatant fraction was assayed for protein (Pier-
ce’s BCA protein reagent). Immunoblotting was performed by
subjecting 10 Wg of solubilized protein to SDS-PAGE and electro-
phoretic transfer of proteins to nitrocellulose membranes [17]. Anti-
bodies for PLC L-1, PLC L-2, PLC L-3, PLC L-4, PLC N-1, PLC Q-1,
and GKq=11 were from Santa Cruz, Transduction Labs, and UBI.
Blotted proteins were visualized using enhanced chemiluminescence
(Amersham).
2.3. Immunoprecipitation of PLC Q-1: determination of protein tyrosine
phosphorylation
Each £ask in a series of cultures was challenged with the desired
vasoactive agent and processed for extraction of protein as described
earlier. Then, 100 Wg protein from each sample was incubated for 30
min with protein A coupled Sepharose beads to adsorb proteins that
non-speci¢cally bind to the beads. Following centrifugation, antibody
for PLC Q-1 was added to the supernatant. The mixture was incubated
overnight at 4‡C. After addition of fresh protein A coupled Sepharose
beads, immunoprecipitates were sedimented, subjected to SDS electro-
phoresis and transferred to nitrocellulose membranes. The membranes
were ¢rst blotted for tyrosine phosphorylated proteins (UBI), stripped
of phosphotyrosine antibody, and then blotted for PLC Q-1.
3. Results
3.1. Increases in [Ca2]i evoked before and after incubation
with genistein
Marked increases in [Ca2]i occurred when the cells were
stimulated with either angiotensin-II, endothelin, serotonin, or
vasopressin (Fig. 1A^D). The increases in [Ca2]i were char-
acterized by an early rapid transient increase in the 340/380
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Fig. 1. Genistein (105 WM/45 min) markedly inhibits transient and
sustained increases in [Ca2]i (340/380 £uorescence ratio) evoked by
stimulation of A10 VSMC with either 50 nM angiotensin-II (A-II,
panel A), 400 nM endothelin (Et, panel B), 1 WM serotonin (S, pan-
el C), 20 nM vasopressin (VP, panel D) or 1 nM PDGF (panel E).
Each curve shows the mean response for the number of cells listed
under each condition. Small vertical bars are þ 1 S.E.M.
Fig. 2. Expression of GKq=11 (panel A) and di¡erent isoforms of
PLC (panel B). Extracts from canine carotid artery (CA), A10 and
A7r5 VSMC, and rat brain (RB) were processed and immunoblot-
ted. The entire immunoblotted gel is shown in panel A, whereas
each row in panel B shows lanes from a di¡erent gel that was im-
munoblotted for the speci¢c isoform of PLC indicated. The appar-
ent Mr for each protein was: GKq=11, 47 000; PLC L-1, 150 000;
PLC L-2, 90 000^100 000; PLC L-3, 140 000; PLC N-1, 88 000; PLC
Q-1, 142 000.
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£uorescence ratio that was followed by a slow decline to a
lower sustained value. Preincubation with 105 WM genistein,
to inhibit tyrosine kinase activity [7,10^15,18], markedly sup-
pressed the early transient increases in [Ca2]i and virtually
abolished the later and smaller sustained increases in [Ca2]i.
Cells stimulated with PDGF, to activate a receptor that ex-
hibits ligand dependent tyrosine kinase activity [7^16], also
induced an increase in [Ca2]i that was blocked with genistein
(Fig. 1E).
3.2. PLC isoforms in VSMC and intact vascular smooth muscle
Proteins corresponding to PLC L-2, PLC L-3, PLC N-1,
PLC Q-1, and GKq=11 were demonstrable in extracts from
A10 VSMC, A7r5 VSMC and from canine carotid artery
(Fig. 2). In contrast, neither PLC L-1 nor PLC L-4 could be
detected in any of these preparations.
3.3. Tyrosine phosphorylation of PLC Q-1
No tyrosine phosphorylation of PLC Q-1 was apparent in
control cells or in response to either angiotensin-II, endothe-
lin, serotonin, or vasopressin (Fig. 3). In contrast, genistein
sensitive tyrosine phosphorylation of PLC Q-1 occurred when
the cells were treated with PDGF.
4. Discussion
The apparent lack of PLC L-1 in intact carotid arterial
smooth muscle and either A10 or A7r5 clonal VSMC (Fig.
2) is consistent with reports from several laboratories showing
that the enzyme is not expressed in VSMC from rat [7] or
rabbit aorta [8] or in extracts from rat mesenteric artery and
aorta [9]. This suggests that we need to re-examine our views
of mechanisms that link activation of G-protein coupled re-
ceptors and increases in [Ca2]i. In this context, Marrero et al.
[7] showed that tyrosine phosphorylation of PLC Q-1 was
functionally linked to increases in [Ca2]i induced by angio-
tensin-II in primary VSMC from adult rats.
In contrast, this study shows that tyrosine phosphorylation
of PLC Q-1 (Fig. 3) does not occur during tyrosine kinase
dependent increases in [Ca2]i evoked by stimulation of A10
VSMC with angiotensin-II. The absence of such phosphoryl-
ation is not re£ective of procedural limitations because tyro-
sine phosphorylation of PLC Q-1 was easily demonstrated
during stimulation of the cells with PDGF (Fig. 3). These
results suggest that angiotensin-II may increase [Ca2]i by
activating di¡erent tyrosine kinase dependent signaling path-
ways in di¡erent types of VSMC.
Stimulation of G-protein coupled receptors for endothelin,
serotonin, or vasopressin also evoked tyrosine kinase depend-
ent increases in [Ca2]i without inducing tyrosine phosphoryl-
ation of PLC Q-1 (Figs. 1 and 3). Nevertheless, the possibility
that tyrosine kinase dependent activation of PLC Q-1 can oc-
cur in the absence of its direct phosphorylation cannot be
discounted. Recent studies in Exton’s laboratory show that
unphosphorylated PLC Q-1 can be activated by forming a
complex with tyrosine phosphorylated PDGF receptor [19].
Conceivably, tyrosine phosphorylation of an unidenti¢ed up-
stream regulatory protein may promote activation of unphos-
phorylated PLC Q-1 in some types of VSMC. Further studies
are required to accept or reject this hypothesis.
Alternatively, it is also possible that a di¡erent isoform of
PLC participates in tyrosine kinase dependent increases in
[Ca2]i. Potential participants include the isoforms we identi-
¢ed (i.e. PLC L-2, L-3, and N-1; Fig. 2) and perhaps other
isoforms that may be present in VSMC. Both, PLC L-2 and L-
3 are attractive candidates because each of the preparations
examined also express GKq=11 (Fig. 2), a subunit(s) of trimeric
G-proteins known to activate PLC L(s) [4^6]. These possibil-
ities assume heightened interest in view of recent observations
indicating that activation of GKq=11 may involve tyrosine
phosphorylation [20].
Taken together, these new data underscore the complexity
of mechanisms that may link stimulation of diverse G-protein
coupled receptors in VSMC to tyrosine kinase dependent ac-
tivation of PLC and increased [Ca2]i.
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